Glycemic & Cardiovascular Outcomes of GLP-1 Receptor Agonists vs. Standard Care in Type 2 Diabetes (N = 180)

STUDY OBJECTIVES

Your study's objectives

Defining your primary objective and study design accurately guides the statistical engine to select the most precise and defensible tests for your research questions.

✓Objectives confirmed · Statistical Analysis Plan (SAP) locked for IRB

STUDY CONTEXT · CONFIRMED

Define your research objective to protect your key variables during cleaning.

Your study objectives are confirmed — your formal SAP protocol will be locked in the Analyze step.

Glycemic & Cardiovascular Outcomes of GLP-1 Receptor Agonists vs. Standard Care in Type 2 Diabetes (N = 180)

01 · PRIMARY OBJECTIVE

To compare 6-month follow-up HbA1c (%) between adult Type 2 Diabetes patients treated with a GLP-1 Receptor Agonist versus Standard Care.

02

STUDY DESIGN

Cohort (Retrospective)

03

SECONDARY OBJECTIVES

  • — To evaluate whether GLP-1 Receptor Agonist therapy reduces 30-day cardiovascular hospital readmission (Readmission_30d).
  • — To assess baseline demographic and clinical balance across treatment arms (Age_Years, Sex, BMI_kg_m2, Smoking_Status, Baseline_HbA1c).
04

KEY VARIABLES

Outcome (Dependent)Followup_6M_HbA1cReadmission_30d
Predictor (Independent)Treatment_Arm
Covariates (Adjusted)Age_YearsSexBMI_kg_m2Smoking_StatusBaseline_HbA1cBlood_Pressure
05

Core Variables Protection Guarantee

Our cleaning engine uses these variables to protect your primary endpoints from accidental modification or exclusion. Your formal Statistical Analysis Plan (SAP) will be locked after data cleaning and Table 1 exploration, right before inferential testing.